BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Increases Stock Position in Ceridian HCM Holding Inc. (NYSE:CDAY)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in Ceridian HCM Holding Inc. (NYSE:CDAY) by 13.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,750 shares of the company’s stock after purchasing an additional 2,974 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Ceridian HCM were worth $2,374,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Signaturefd LLC raised its stake in Ceridian HCM by 52.5% in the first quarter. Signaturefd LLC now owns 331 shares of the company’s stock valued at $28,000 after purchasing an additional 114 shares in the last quarter. Xponance Inc. raised its stake in Ceridian HCM by 0.9% in the first quarter. Xponance Inc. now owns 22,293 shares of the company’s stock valued at $1,879,000 after purchasing an additional 208 shares in the last quarter. DekaBank Deutsche Girozentrale raised its stake in Ceridian HCM by 1.5% in the second quarter. DekaBank Deutsche Girozentrale now owns 15,604 shares of the company’s stock valued at $1,545,000 after purchasing an additional 233 shares in the last quarter. CIBC Asset Management Inc raised its stake in Ceridian HCM by 4.3% in the first quarter. CIBC Asset Management Inc now owns 5,824 shares of the company’s stock valued at $491,000 after purchasing an additional 238 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Ceridian HCM by 0.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 43,685 shares of the company’s stock valued at $3,681,000 after purchasing an additional 251 shares in the last quarter.

In other news, COO Leagh Erin Turner sold 6,000 shares of Ceridian HCM stock in a transaction dated Thursday, July 15th. The stock was sold at an average price of $95.55, for a total value of $573,300.00. Following the completion of the transaction, the chief operating officer now owns 119,111 shares of the company’s stock, valued at approximately $11,381,056.05. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO David D. Ossip sold 750,000 shares of the business’s stock in a transaction dated Wednesday, August 11th. The stock was sold at an average price of $102.45, for a total value of $76,837,500.00. Following the completion of the transaction, the chief executive officer now directly owns 1,309,873 shares of the company’s stock, valued at approximately $134,196,488.85. The disclosure for this sale can be found here. Insiders have sold 764,736 shares of company stock valued at $78,395,347 in the last three months. Insiders own 4.00% of the company’s stock.

Shares of Ceridian HCM stock opened at $109.17 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $16.36 billion, a P/E ratio of -253.88 and a beta of 1.40. The business has a fifty day simple moving average of $104.67 and a two-hundred day simple moving average of $94.74. Ceridian HCM Holding Inc. has a 12 month low of $71.57 and a 12 month high of $116.70.

Ceridian HCM (NYSE:CDAY) last announced its quarterly earnings data on Wednesday, August 4th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03. The business had revenue of $250.40 million during the quarter, compared to analyst estimates of $238.48 million. Ceridian HCM had a negative return on equity of 1.15% and a negative net margin of 6.92%. The company’s revenue for the quarter was up 30.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.13 earnings per share. Analysts predict that Ceridian HCM Holding Inc. will post -0.29 earnings per share for the current year.

A number of brokerages recently weighed in on CDAY. Barclays downgraded shares of Ceridian HCM from an “equal weight” rating to an “underweight” rating and set a $98.00 target price on the stock. in a research note on Wednesday, June 30th. Wells Fargo & Company lifted their price target on shares of Ceridian HCM from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 5th. Jefferies Financial Group decreased their price target on shares of Ceridian HCM from $110.00 to $95.00 in a research note on Friday, May 28th. Piper Sandler lifted their price target on shares of Ceridian HCM from $108.00 to $110.00 and gave the stock a “neutral” rating in a research note on Thursday, August 5th. Finally, Needham & Company LLC downgraded shares of Ceridian HCM from a “buy” rating to a “hold” rating in a research note on Tuesday, June 15th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Ceridian HCM presently has a consensus rating of “Hold” and an average price target of $106.54.

Ceridian HCM Profile

Ceridian HCM Holding, Inc engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. The Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels.

Recommended Story: Forex

Want to see what other hedge funds are holding CDAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ceridian HCM Holding Inc. (NYSE:CDAY).

Institutional Ownership by Quarter for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.